Downloads

Downloads

Current Presentations

Date Title File
Nov 18, 2024
Immatics Corporate Presentation November 2024
Nov 18, 2024
TCR Bispecific Molecule TCER® IMA402 Targeting PRAME - Phase 1 Dose Escalation Clinical Data Update
Nov 08, 2024
Enhanced Pharmacology Data of Next-generation IMA203CD8 TCR-T Monotherapy Targeting PRAME
Nov 08, 2024
Combination of a TCR-engineered Autologous PRAME-targeting T Cell Therapy with a PRAME-encoding mRNA for the Treatment of Solid Tumors
Nov 08, 2024
ACTengine® IMA203 TCR-T Targeting PRAME Shows Deep and Durable Anti-Tumor Activity in Heavily Pretreated Solid Cancer Patients
Oct 10, 2024
ACTengine® IMA203 TCR-T Targeting PRAME in PD1 Refractory Metastatic Melanoma - Phase 1b Dose Expansion Clinical Data Update
Sep 16, 2024
TCER® IMA401 Targeting MAGEA4/8 - Phase 1 Dose Escalation Clinical Data Update
Nov 08, 2023
ACTengine® IMA203 & IMA203CD8 TCR-T Monotherapy Targeting PRAME - Phase 1 Interim Data Update
Nov 08, 2023
ACTengine® IMA203 Clinical Data Update at Society for Melanoma Research Congress, November 2023
Nov 10, 2022
PRAME Target Presentation at SITC Annual Meeting, November 2022

Archive

Date Title File
Nov 10, 2020
Immatics ACTolog® IMA101 Phase-1-Data at the 35th Annual SITC conference

Media Materials